Evidence map›Paper›PMID 26721414›Full record

ArticleBiointerphases2015

C60-SIMS imaging of nanoparticles within mammalian cells.

Anna N Bloom, Hua Tian, Nicholas Winograd

Abstract read
In one paragraph

Article in Biointerphases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna N BloomDepartment of Chemistry, The Pennsylvania State University, 104 Chemistry Building, University Park, Pennsylvania 16802.
Hua TianDepartment of Chemistry, The Pennsylvania State University, 104 Chemistry Building, University Park, Pennsylvania 16802.
Nicholas WinogradDepartment of Chemistry, The Pennsylvania State University, 104 Chemistry Building, University Park, Pennsylvania 16802.

Funding

IMAGING MASS SPECTROMETRY RESEARCH RESOURCE AT VANDERBILT UNIVERSITYP41RR031461 · NCRR · VANDERBILT UNIVERSITY · PI CAPRIOLI, RICHARD M · 2011 to 2011
$2.2M
Molecular Imaging of Biomaterials - Single CellsR01GM113746 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI WINOGRAD, NICHOLAS · 2014 to 2017
$1.7M
NCRR NIH HHS 5P41RR031461NCRR NIH HHS P41 RR031461NIGMS NIH HHS R01 GM113746NIGMS NIH HHS R01GM113746-21
6 · The paper itself

Abstract

To achieve successful drug delivery via nanoparticles the interactions between the nanoparticle and the chemistry of the surrounding biological environment is of central importance. A thorough understanding of these interactions is necessary in order to better elucidate information regarding drug pathways and mechanisms of action in treatment protocols. As such, it is important to identify the location of the nanoparticle, the state of its functionalization, as well as any changes in the cellular environment. The use of cluster secondary ion mass spectrometry (SIMS) using C60 (+) primary ions makes simultaneous acquisition of this information possible. Here, SIMS has been successfully used to chemically image gold nanoparticles (AuNPs) within a model, single cell system involving macrophage-like RAW 264.7 cells. The macrophage-like properties of this cell line make it extremely well-suited for cell-uptake studies. Both AuNPs and two pharmaceutical compounds, amiodarone and elacridar, were successfully imaged within a cellular system using cluster SIMS. To verify that SIMS can also be used to detect functionalization and nanoparticles simultaneously, fluorophore-functionalized AuNPs were studied as a model system. The fluorescent characteristics of these functionalized nanoparticles enabled the visual confirmation of the presence and location of the particles within the cell.

Indexed as

AcridinesAmiodaroneAnimalsAnti-Arrhythmia AgentsDrug CarriersFullerenesGoldImage Processing, Computer-AssistedMacrophagesMiceNanoparticlesRAW 264.7 CellsSpectrometry, Mass, Secondary IonStaining and LabelingTetrahydroisoquinolinesAcridinesAmiodaroneAnti-Arrhythmia AgentsDrug CarriersElacridarfullerene C60FullerenesGoldTetrahydroisoquinolines

Identifiers

PMID26721414
PMCPMC4698117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.